Use of carbapenems and glycopepdides is significant risk for multidrug resistant Acinetobacter baumannii infections
Salih Hosoglu1, Eyup Arslan2, Emel Aslan3
1Fatih University, Istanbul, Turkey. hosoglu@hotmail.com.
Introduction:
Multi-drug resistant Acinetobacter baumannii (MDR-Ab) infections are an important healthcare problem globally. The aim of this study was to evaluate risk factors associated with MDR-Ab infections in hospitalized patients in Turkey.
Methodology:
A case-control study was performed in a tertiary care 1,303-bed university hospital, among case patients with MDR-Ab infections. The hospital records of case and control patients were retrospectively evaluated over a year. Patients who were hospitalized in the same department and in the same time interval as the case patients, without MDR-Ab infection or colonization, were chosen for control group. Demographic characteristics, Acute Physiology And Chronic Health Evaluation II (APACHE II) scores, comorbid diseases, use of invasive tools and duration of usage, and duration of use of antibiotics were recorded for all patients. Comparisons between case and control groups for possible risk factors were performed.
Results:
In total, 95 cases and 95 controls were included in the study. Univariate analysis highlighted several variables as risk factors for MDR-Ab infections. Multivariate analysis showed that only antibiotic usage over seven days (OR = 2.38, CI = 1.18-4.83, p = 0.016) was found to be a significant risk factor. When antibiotic treatment patterns in both groups were compared, the use of carbapenems (p = 0.001) and glycopeptide antibiotics (p=0.001) in patient treatment were found significantly higher in the MDR-Ab case group.
Conclusion:
This study showed us that previous antibiotic use is a significant risk factor for MDR-Ab infections. The use of carbapenems and glycopeptides should be considered as primary risk factors for developing MDR-Ab infection.
Insights
Previous antibiotic use, particularly carbapenems and glycopeptides, significantly increases the risk of developing multi-drug resistant Acinetobacter baumannii (MDR-Ab) infections in hospitalized patients. This finding highlights the importance of judicious antibiotic stewardship to combat MDR-Ab.
Area of Science:
- Infectious Diseases
- Clinical Microbiology
- Hospital Epidemiology
Background:
- Multi-drug resistant Acinetobacter baumannii (MDR-Ab) poses a significant global healthcare challenge.
- Identifying risk factors for MDR-Ab infections is crucial for effective infection control strategies.
Purpose of the Study:
- To evaluate risk factors associated with MDR-Ab infections in hospitalized patients in Turkey.
- To identify specific antibiotic classes contributing to MDR-Ab development.
Main Methods:
- A case-control study was conducted in a tertiary care university hospital.
- Retrospective analysis of hospital records for 95 MDR-Ab cases and 95 controls.
- Data collected included demographics, APACHE II scores, comorbidities, invasive device use, and antibiotic exposure duration.
Main Results:
- Antibiotic usage exceeding seven days was a significant risk factor (OR = 2.38, p = 0.016).
- The MDR-Ab case group showed significantly higher use of carbapenems (p = 0.001) and glycopeptide antibiotics (p = 0.001).
Conclusions:
- Previous antibiotic use is a significant risk factor for MDR-Ab infections.
- Carbapenem and glycopeptide use are primary risk factors for developing MDR-Ab infection.
More Related Videos
08:37The Application of Open Searching-based Approaches for the Identification of Acinetobacter baumannii O-linked Glycopeptides
Published on: November 2, 2021
12:03Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method
Published on: April 18, 2019
Related Concept Videos
Development of Antibiotic Resistance
Acute Pyelonephritis II: Diagnostic Studies and Management
Antibiotic Selection
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Gene Regulation in Microbial Communities: Quorum Sensing
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
